Graphic by Jason Drees/Biodesign Institute

All eyes on Alzheimer’s

In honor of Sept. 21 World Alzheimer’s Day, a look at related research at ASU.

Alzheimer’s, a mysterious disease of cognitive decline, was first recognized a century ago. The unremitting illness continues to frustrate the best efforts toward treatment or prevention, and a tidal wave of new cases in the coming decades threatens to overwhelm the nation’s health-care system.

By 2050, Alzheimer’s is expected to strike one new patient in the U.S. every 33 seconds, resulting in nearly 1 million new cases per year. It remains the only leading killer for which no effective therapy exists.

Arizona State University is intimately involved in the war against this disease and has recently formed a path-breaking, interdisciplinary contingent of leading researchers known as the ASU-Banner Neurodegenerative Disease Research Center (NDRC).

Arizona State University and Banner Health have formed a new research alliance to advance the scientific study, treatment and prevention of Alzheimer’s, Parkinson’s and other neurodegenerative diseases. The partnership between Arizona State University (ASU), one of the nation’s largest public research universities, and Phoenix-based Banner Health, one of the nation’s largest nonprofit health systems, includes the launch of the Arizona State University-Banner Neurodegenerative Disease Research Center on ASU’s Tempe campus. — See more at: biodesign.asu.edu/news/arizona-state-university-and-banner-health-launch-major-effort-fight-neurodegenerative-diseases#sthash.rZOtxpt2.dpuf

Official Medium account of ASU. № 1 in innovation. Top 10 of all universities worldwide for U.S. patents awarded. Find more ASU news at asunow.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store